In addition to the GLP-1 peptide delivery strategies, the activation of a GLP-1 receptor by the exogenous introduction of GLP-1 nucleic acid is another promising strategy for the treatment of hyperglycemia and obesity [282]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.